Integral Ad Science Holding Corp. (NASDAQ:IAS – Get Free Report) was the recipient of a large decline in short interest in the month of July. As of July 15th, there was short interest totalling 6,630,000 shares, a decline of 6.9% from the June 30th total of 7,120,000 shares. Based on an average daily volume of 1,670,000 shares, the short-interest ratio is presently 4.0 days. Currently, 9.3% of the shares of the company are sold short.
Integral Ad Science Trading Down 5.4 %
Shares of NASDAQ IAS traded down $0.58 during midday trading on Wednesday, reaching $10.18. 1,789,140 shares of the stock were exchanged, compared to its average volume of 1,695,096. Integral Ad Science has a twelve month low of $7.98 and a twelve month high of $20.88. The stock has a market capitalization of $1.63 billion, a P/E ratio of 1,018.00, a PEG ratio of 1.85 and a beta of 1.53. The company has a 50 day simple moving average of $9.79 and a 200 day simple moving average of $11.05. The company has a debt-to-equity ratio of 0.13, a quick ratio of 4.32 and a current ratio of 4.32.
Integral Ad Science (NASDAQ:IAS – Get Free Report) last posted its earnings results on Thursday, May 9th. The company reported ($0.01) EPS for the quarter, meeting analysts’ consensus estimates of ($0.01). The company had revenue of $114.50 million for the quarter, compared to the consensus estimate of $112.12 million. Integral Ad Science had a return on equity of 0.32% and a net margin of 0.59%. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.02 earnings per share. As a group, equities analysts expect that Integral Ad Science will post 0.22 earnings per share for the current year.
Analyst Upgrades and Downgrades
Read Our Latest Research Report on IAS
Insider Activity at Integral Ad Science
In other news, CEO Lisa Utzschneider sold 8,044 shares of the stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $9.97, for a total transaction of $80,198.68. Following the sale, the chief executive officer now directly owns 203,139 shares of the company’s stock, valued at approximately $2,025,295.83. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, CAO Alexis Gil II sold 2,792 shares of Integral Ad Science stock in a transaction on Tuesday, June 4th. The shares were sold at an average price of $9.09, for a total value of $25,379.28. Following the sale, the chief accounting officer now owns 145,550 shares of the company’s stock, valued at approximately $1,323,049.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Lisa Utzschneider sold 8,044 shares of the company’s stock in a transaction on Monday, May 6th. The stock was sold at an average price of $9.97, for a total transaction of $80,198.68. Following the transaction, the chief executive officer now owns 203,139 shares of the company’s stock, valued at $2,025,295.83. The disclosure for this sale can be found here. Insiders sold a total of 22,478 shares of company stock worth $218,311 in the last three months. Company insiders own 2.00% of the company’s stock.
Institutional Investors Weigh In On Integral Ad Science
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Ameritas Investment Partners Inc. lifted its stake in Integral Ad Science by 40.1% during the 1st quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock worth $67,000 after acquiring an additional 1,924 shares in the last quarter. ProShare Advisors LLC acquired a new stake in shares of Integral Ad Science during the first quarter worth about $121,000. American Trust boosted its stake in shares of Integral Ad Science by 18.0% in the first quarter. American Trust now owns 13,742 shares of the company’s stock valued at $137,000 after purchasing an additional 2,096 shares during the period. Vontobel Holding Ltd. acquired a new position in shares of Integral Ad Science in the fourth quarter valued at approximately $176,000. Finally, Price T Rowe Associates Inc. MD increased its stake in Integral Ad Science by 55.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 19,215 shares of the company’s stock worth $192,000 after buying an additional 6,878 shares during the period. 95.78% of the stock is owned by hedge funds and other institutional investors.
Integral Ad Science Company Profile
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Recommended Stories
- Five stocks we like better than Integral Ad Science
- ESG Stocks, What Investors Should Know
- Joby Aviation Stock: The Case for Upside Just Got Stronger
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Conviction Firms for Microsoft’s Double-Digit Stock Upside
- 3 Small Caps With Big Return Potential
- 5 Aggressive Growth Stocks for Long-Term Investors
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.